Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Yang, Wan Zhang ^a   Zhang, Yun ^b   Wu, Fang ^a   Min, Wei Ping ^c   Minev, Boris ^d   Zhang, Min ^a   Luo, Xiao Ling ^b   Ramos, Famela ^e   Ichim, Thomas E ^e   Riordan, Neil H ^e   Hu, Xiang ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b Shenzhen Beike Cell Engineering Research Institute   (China)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e Medistem Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ALLOTRANSPLANTATION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATAXIA; BIOCHEMISTRY; BRACHIAL PLEXUS INJURY; BRAIN DISEASE; CELL THERAPY; CEREBRAL PALSY; CEREBROVASCULAR DISEASE; CERVICAL SPONDYLOSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; FEVER; HEADACHE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; IMMUNOLOGICAL PARAMETERS; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; OPTIC NERVE HYPOPLASIA; PAIN; PARAPLEGIA; SAFETY; SHIVERING; SHY DRAGER SYNDROME; TRAUMATIC BRAIN INJURY; UMBILICAL CORD BLOOD; VOMITING; BLOOD; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; FETUS BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 77955105738     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-75     Document Type: Article

References (21)

1. Javed MJ, Mead LE, Prater D, Bessler WK, Foster D, Case J, Goebel WS, Yoder MC, Haneline LS, Ingram DA. Endothelial colony forming cells and mesenchymal stem cells are enriched at different gestational ages in human umbilical cord blood. Pediatr Res 2008, 64:68-73. 10.1203/PDR.0b013e31817445e9, 18360305.
2. Hutton JF, Gargett T, Sadlon TJ, Bresatz S, Brown CY, Zola H, Shannon MF, D'Andrea RJ, Barry SC. Development of CD4+CD25+FoxP3+ regulatory T cells from cord blood hematopoietic progenitor cells. J Leukoc Biol 2009, 85:445-451. 10.1189/jlb.1008620, 19103952.
3. Gratwohl A, Baldomero H. Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol 2009, 16:420-426. 10.1097/MOH.0b013e328330990f, 19680124.
4. Haller MJ, Wasserfall CH, McGrail KM, Cintron M, Brusko TM, Wingard JR, Kelly SS, Shuster JJ, Atkinson MA, Schatz DA. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 2009, 32:2041-2046. 10.2337/dc09-0967, 19875605.
5. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol 2009, 147:177-184. 10.1111/j.1365-2141.2009.07767.x, 19796266.
6. Liu WS, Chen CT, Foo NH, Huang HR, Wang JJ, Chen SH, Chen TJ. Human umbilical cord blood cells protect against hypothalamic apoptosis and systemic inflammation response during heatstroke in rats. Pediatr Neonatol 2009, 50:208-216. 10.1016/S1875-9572(09)60065-6, 19856864.
7. Hwang WS, Chen SH, Lin CH, Chang HK, Chen WC, Lin MT. Human umbilical cord blood-derived CD34+ cells can be used as a prophylactic agent for experimental heatstroke. J Pharmacol Sci 2008, 106:46-55. 10.1254/jphs.FP0071567, 18187924.
8. Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC, Hudson JE, Chen N, Davis CD, Sanberg PR. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 2003, 12:255-270. 10.1089/152581603322022990, 12857367.
9. Xing YL, Shen LH, Li HW, Zhang YC, Zhao L, Zhao SM, Xu Q. Optimal time for human umbilical cord blood cell transplantation in rats with myocardial infarction. Chin Med J (Engl) 2009, 122:2833-2839.
10. Moon YJ, Yoon HH, Lee MW, Jang IK, Lee DH, Lee JH, Lee SK, Lee KH, Kim YJ, Eom YW. Multipotent progenitor cells derived from human umbilical cord blood can differentiate into hepatocyte-like cells in a liver injury rat model. Transplant Proc 2009, 41:4357-4360. 10.1016/j.transproceed.2009.08.053, 20005398.
11. Bachstetter AD, Pabon MM, Cole MJ, Hudson CE, Sanberg PR, Willing AE, Bickford PC, Gemma C. Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci 2008, 9:22. 10.1186/1471-2202-9-22, 2268935, 18275610.
12. Xiao J, Nan Z, Motooka Y, Low WC. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev 2005, 14:722-733. 10.1089/scd.2005.14.722, 16433627.
13. Riordan NH, Chan K, Marleau AM, Ichim TE. Cord blood in regenerative medicine: do we need immune suppression?. J Transl Med 2007, 5:8. 10.1186/1479-5876-5-8, 1796850, 17261200.
14. Ghen MJ, Roshan R, Roshan RO, Blyweiss DJ, Corso N, Khalili B, Zenga WT. Potential clinical applications using stem cells derived from human umbilical cord blood. Reprod Biomed Online 2006, 13:562-572. 10.1016/S1472-6483(10)60646-3, 17007681.
15. Ichim TE, Solano F, Brenes R, Glenn E, Chang J, Chan K, Riordan NH. Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reprod Biomed Online 2008, 16:898-905. 10.1016/S1472-6483(10)60159-9, 18549704.
16. Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 2009, 7:29. 10.1186/1479-5876-7-29, 2679713, 19393041.
17. Ichim TE, Alexandrescu DT, Solano F, Lara F, Campion Rde N, Paris E, Woods EJ, Murphy MP, Dasanu CA, Patel AN, Marleau AM, Leal A, Riordan NH. Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol 260:75-82. 10.1016/j.cellimm.2009.10.006, 19917503.
18. Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, Lee JE, Kim YJ, Yang SK, Jung HL, Sung KW, Kim CW, Koo HH. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 2009, 259:150-156. 10.1016/j.cellimm.2009.06.010, 19608159.
19. Hwang JH, Shim SS, Seok OS, Lee HY, Woo SK, Kim BH, Song HR, Lee JK, Park YK. Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow. J Korean Med Sci 2009, 24:547-554. 10.3346/jkms.2009.24.4.547, 2719209, 19654931.
20. Jiang ChF WCX, Fu Y. Adverse reactions to blood transfusion and transfusion transmitted disease. 2004, 222. GuangDong, CHINA, Guangdong Science and Technology press, 1.
21. Peng CT, Lin HC, Lin YJ, Tsai CH, Yeh TF. Early Dexamethasone Therapy and Blood Cell Count in Preterm Infants. Pediatrics 1999, 104:476-481. 10.1542/peds.104.3.476, 10469772.